These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31108132)

  • 1. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis.
    Zeng Q; Junli Gong ; Liu X; Chen C; Sun X; Li H; Zhou Y; Cui C; Wang Y; Yang Y; Wu A; Shu Y; Hu X; Lu Z; Zheng SG; Qiu W; Lu Y
    Neurochem Int; 2019 Oct; 129():104468. PubMed ID: 31108132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of short-chain fatty acids and overgrowth of opportunistic pathogens define dysbiosis of neuromyelitis optica spectrum disorders: A Chinese pilot study.
    Gong J; Qiu W; Zeng Q; Liu X; Sun X; Li H; Yang Y; Wu A; Bao J; Wang Y; Shu Y; Hu X; Bellanti JA; Zheng SG; Lu Y; Lu Z
    Mult Scler; 2019 Aug; 25(9):1316-1325. PubMed ID: 30113252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome.
    Xie Q; Sun J; Sun M; Wang Q; Wang M
    Mult Scler Relat Disord; 2024 Dec; 92():105936. PubMed ID: 39418776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis.
    Moles L; Delgado S; Gorostidi-Aicua M; Sepúlveda L; Alberro A; Iparraguirre L; Suárez JA; Romarate L; Arruti M; Muñoz-Culla M; Castillo-Triviño T; Otaegui D;
    Front Immunol; 2022; 13():960761. PubMed ID: 36325343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
    Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
    Front Immunol; 2020; 11():1390. PubMed ID: 32733460
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab-induced gut microbiota changes in Chinese neuromyelitis optica spectrum disorders.
    Chen H; Xu Z; Zhou Y; Jiang YH; Chen J; Xiong Y; Zhou M; Wu X; Hong D
    Mult Scler Relat Disord; 2024 Jun; 86():105606. PubMed ID: 38636269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
    Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
    Front Immunol; 2020; 11():1994. PubMed ID: 32973805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.
    Olsson A; Gustavsen S; Nguyen TD; Nyman M; Langkilde AR; Hansen TH; Sellebjerg F; Oturai AB; Bach Søndergaard H
    Front Immunol; 2021; 12():661493. PubMed ID: 34025661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Gut Microbiota and Multiple Sclerosis: A Systematic Review.
    Ordoñez-Rodriguez A; Roman P; Rueda-Ruzafa L; Campos-Rios A; Cardona D
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
    Shi Z; Qiu Y; Wang J; Fang Y; Zhang Y; Chen H; Du Q; Zhao Z; Yan C; Yang M; Zhou H
    J Neuroimmunol; 2020 Feb; 339():577126. PubMed ID: 31841737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.
    Barcutean L; Maier S; Burai-Patrascu M; Farczadi L; Balasa R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-chain fatty acids and gut microbiota in multiple sclerosis.
    Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
    Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes.
    Tan C; Wu Q; Wang H; Gao X; Xu R; Cui Z; Zhu J; Zeng X; Zhou H; He Y; Yin J
    JPEN J Parenter Enteral Nutr; 2021 Mar; 45(3):518-529. PubMed ID: 32473086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis.
    Takewaki D; Suda W; Sato W; Takayasu L; Kumar N; Kimura K; Kaga N; Mizuno T; Miyake S; Hattori M; Yamamura T
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22402-22412. PubMed ID: 32839304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronotropic and vasoactive properties of the gut bacterial short-chain fatty acids in larval zebrafish.
    Sree Kumar H; Wisner AS; Schiefer IT; Alviter Plata A; Zubcevic J
    Physiol Genomics; 2024 Jun; 56(6):426-435. PubMed ID: 38557279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota and Derived Short-Chain Fatty Acids Are Linked to Evolution of Heart Failure Patients.
    Modrego J; Ortega-Hernández A; Goirigolzarri J; Restrepo-Córdoba MA; Bäuerl C; Cortés-Macías E; Sánchez-González S; Esteban-Fernández A; Pérez-Villacastín J; Collado MC; Gómez-Garre D
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.
    Harbison JE; Roth-Schulze AJ; Giles LC; Tran CD; Ngui KM; Penno MA; Thomson RL; Wentworth JM; Colman PG; Craig ME; Morahan G; Papenfuss AT; Barry SC; Harrison LC; Couper JJ
    Pediatr Diabetes; 2019 Aug; 20(5):574-583. PubMed ID: 31081243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease.
    Wang F; Qian F; Zhang Q; Zhao J; Cen J; Zhang J; Zhou J; Luo M; Jia C; Rong X; Chu M
    Front Immunol; 2023; 14():1124118. PubMed ID: 37398673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.
    Kaur H; Golovko S; Golovko MY; Singh S; Darland DC; Combs CK
    J Alzheimers Dis; 2020; 76(3):1083-1102. PubMed ID: 32623399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.